Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

Background & Aims. The article presents results of two observational, prospective, multicenter studies “Quality of Life, Symptom Profile, and Adherence to Treatment in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Receiving Dasatinib” (2012–2015) and “Quality of Life...

Full description

Saved in:
Bibliographic Details
Main Authors: TI Ionova, NB Bulieva, OYu Vinogradova, TA Gritsenko, LK Kozlova, GB Kuchma, EG Lomaia, ER Machyulaitene, TP Nikitina, NV Novitskaya, AYu Rodionova, EI Usacheva, TV Shneider
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2017-04-01
Series:Клиническая онкогематология
Subjects:
quality of life
chronic myeloid leukemia
dasatinib
therapy effectiveness
therapy safety
routine clinical practice
Online Access:http://bloodjournal.ru/wp-content/uploads/2017/03/10.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://bloodjournal.ru/wp-content/uploads/2017/03/10.pdf

Similar Items